Inhibition of IKKβ by a quinoxaline urea inhibitor, synthesized by Radhakrishnan et al. in 2021, also displayed the antiproliferative effect against pancreatic cancer cells T3M4 and MiaPaCa2 65. Here, IKBKB is linked to familial pancreatic carcinoma.